These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22989833)

  • 1. Low-density lipoprotein apheresis therapy for steroid- and cyclosporine-resistant idiopathic membranous nephropathy.
    Sato Y; Tsunoda S; Nozue T; Pan Q; Wakasugi H; Yoshimura A
    Intern Med; 2012; 51(18):2597-602. PubMed ID: 22989833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Low-Density Lipoprotein Apheresis for Nephrotic Idiopathic Membranous Nephropathy as Initial Induction Therapy.
    Koshi-Ito E; Koike K; Tanaka A; Watanabe Y; Kamegai N; Shimogushi H; Shinjo H; Otsuka Y; Inaguma D; Takeda A
    Ther Apher Dial; 2019 Dec; 23(6):575-583. PubMed ID: 30993827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term Low-density Lipoprotein Apheresis in a Patient with Refractory Idiopathic Membranous Glomerulonephritis.
    Yabuuchi J; Suwabe T; Mizuno H; Ueno T; Hoshino J; Sekine A; Kawada M; Yamanouchi M; Hayami N; Hiramatsu R; Hasegawa E; Sawa N; Takaichi K; Fujii T; Ohashi K; Ubara Y
    Intern Med; 2017; 56(12):1543-1547. PubMed ID: 28626181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid normalization of interleukin-8 production after low-density lipoprotein apheresis in steroid-resistant nephrotic syndrome.
    Sakurai M; Muso E; Matushima H; Ono T; Sasayama S
    Kidney Int Suppl; 1999 Jul; 71():S210-2. PubMed ID: 10412778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-density lipoprotein apheresis for PLA2R-related membranous glomerulonephritis accompanied by IgG4-related tubulointerstitial nephritis.
    Nishizawa Y; Honda K; Aoyama Y; Hosoda Y; Tamura T; Horimoto A; Omae K; Higuchi C; Sakura H; Nitta K; Ogawa T
    CEN Case Rep; 2020 Nov; 9(4):395-403. PubMed ID: 32557252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial.
    Cattran DC; Appel GB; Hebert LA; Hunsicker LG; Pohl MA; Hoy WE; Maxwell DR; Kunis CL;
    Kidney Int; 2001 Apr; 59(4):1484-90. PubMed ID: 11260412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment-resistant PLA2R-negative membranous nephropathy responsive to low-density lipoprotein apheresis.
    Szymanski JM; Waldman M; Conry-Cantilena C; West KA
    J Clin Apher; 2019 Aug; 34(4):495-498. PubMed ID: 30537217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does LDL-apheresis in steroid-resistant nephrotic syndrome affect prognosis?
    Muso E; Yashiro M; Matsushima M; Yoshida H; Sawanishi K; Sasayama S
    Nephrol Dial Transplant; 1994; 9(3):257-64. PubMed ID: 8052431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low density lipoprotein apheresis therapy for steroid-resistant nephrotic syndrome. Kansai-FGS-Apheresis Treatment (K-FLAT) Study Group.
    Muso E; Mune M; Fujii Y; Imai E; Ueda N; Hatta K; Imada A; Miki S; Kuwahara T; Takamitsu Y; Takemura T; Tsubakihara Y
    Kidney Int Suppl; 1999 Jul; 71():S122-5. PubMed ID: 10412754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of low-density lipoprotein-apheresis on nephrotic syndrome due to membranous nephropathy in renal allograft: a case report.
    Ideura T; Hora K; Kaneko Y; Yamazaki T; Tokunaga S; Shigematsu H; Kiyosawa K
    Transplant Proc; 2000 Feb; 32(1):223-6. PubMed ID: 10701029
    [No Abstract]   [Full Text] [Related]  

  • 11. [Steroid and cyclosporine therapy in idiopathic membranous nephropathy: monocentric experience and literature review].
    Zotta F; Di Stasio E; Manzione A; Pirozzi N; Stoppacciaro A; Menè P
    G Ital Nefrol; 2019 Jun; 36(3):. PubMed ID: 31251003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term cyclosporin A therapy for severe idiopathic membranous nephropathy.
    Rostoker G; Belghiti D; Ben Maadi A; Rémy P; Lang P; Weil B; Lagrue G
    Nephron; 1993; 63(3):335-41. PubMed ID: 8446273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case report of nephrotic syndrome due to collapsing focal segmental glomerulosclerosis treated with low-density lipoprotein apheresis.
    Miyazono M; Tomiyoshi Y; Kishi T; Ikeda Y; Sakemi T; Sanai T; Node K
    Ther Apher Dial; 2008 Aug; 12(4):333-6. PubMed ID: 18789122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine treatment in idiopathic membranous nephropathy nephrotic syndrome in adults: a retrospective study spanning 15 years.
    Tao JL; Liu LL; Wen YB; Gao RT; Li H; Li MX; Li XM; Li XW
    Chin Med J (Engl); 2011 Nov; 124(21):3490-4. PubMed ID: 22340164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triple therapy with single daily dose of cyclosporine in Japanese patients with idiopathic membranous nephropathy.
    Matsumoto H; Nagaoka Y; Okada T; Wada T; Gondo A; Esaki S; Hayashi A; Miyaoka Y; Nakao T
    Intern Med; 2011; 50(18):1905-10. PubMed ID: 21921367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting the long-term outcomes of idiopathic membranous nephropathy.
    Huh H; Lee H; Lee JP; Kim DK; Oh S; Oh YK; Kim YS; Lim CS
    BMC Nephrol; 2017 Mar; 18(1):104. PubMed ID: 28347297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membranous nephropathy complicated by immune thrombocytopenia treated with low-density lipoprotein apheresis: a case report and literature review.
    Nishizawa K; Yamashita T; Ogawa Y; Kobayashi H
    CEN Case Rep; 2022 Feb; 11(1):43-49. PubMed ID: 34287815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine versus azathioprine therapy in high-risk idiopathic membranous nephropathy patients: A 3-year prospective study.
    Naumovic R; Jovanovic D; Pavlovic S; Stosovic M; Marinkovic J; Basta-Jovanovic G
    Biomed Pharmacother; 2011 Mar; 65(2):105-10. PubMed ID: 21109389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological Features of Idiopathic Membranous Nephropathy in 33 Adolescents.
    Li C; Li H; Wen YB; Li JN; Lin WF; Cai JF; Duan L; Li Y; Li XM; Li XW
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):544-551. PubMed ID: 28877834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan.
    Shiiki H; Saito T; Nishitani Y; Mitarai T; Yorioka N; Yoshimura A; Yokoyama H; Nishi S; Tomino Y; Kurokawa K; Sakai H;
    Kidney Int; 2004 Apr; 65(4):1400-7. PubMed ID: 15086481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.